Overview
Patients are Talking: Change is Needed in How We Manage Endometriosis
Endometriosis Expert Perspectives
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
The average time to an endometriosis (EM) diagnosis continues to be a staggering 10 years, though this time may be even longer in women of color. Clinicians need to learn how to address these ongoing delays in EM care. Hear real patient stories and learn real-world strategies to reduce diagnostic delays, address treatment misconceptions, and navigate challenges in care that racially diverse women face at incomparable rates. Learn about the limitations with conventional EM treatment options and surgery as well as with the promising role of newer GnRH receptor antagonists in managing EM-related pain.
This educational activity is designed for clinicians who treat patients with EM (OB/GYNs, internists, primary care providers, nurses, and other healthcare professionals).
Despite EM’s prevalence, its diagnosis is typically delayed by years, misdiagnosis is common, and delivery of effective therapy is prolonged, particularly in culturally diverse women. Of concern, EM has such wide-ranging and pervasive sequelae that it has been described as “nothing short of a public health emergency” requiring immediate action. Though one-third of patients with EM may be asymptomatic, patients with EM may present with symptoms such as dysmenorrhea, heavy or irregular bleeding, pelvic pain, lower abdominal or back pain, and dyschezia. Clinicians on the multidisciplinary EM team must become better informed about the need for prompt recognition and care of patients with EM.
Clinicians also need to better understand the limitations with present surgical and conventional medication interventions for EM. The newer gonadotropin-releasing hormone (GnRH) receptor antagonist class – which continues to expand with one agent recently approved and two more in late-stage development – was developed to help overcome many of the setbacks with these traditional EM treatment methods. It is important that clinicians on the interdisciplinary EM team are aware of these novel agents.
Upon completion of this activity, learners will be able to:
- Describe the clinical and economic burden of EM
- Explore how clinical and non-invasive tools may facilitate earlier diagnosis and treatment of EM and improve outcomes in diverse patients
- Outline limitations with conventional treatment strategies for EM and review new opportunities with GnRH antagonists
- Evaluate the latest safety, efficacy, and clinical differentiators of the GnRH antagonists in improving long-term outcomes for EM management
- Describe the clinical and economic burden of EM
- Explore how clinical and non-invasive tools may facilitate earlier diagnosis and treatment of EM and improve outcomes in diverse patients
- Outline limitations with conventional treatment strategies for EM and review new opportunities with GnRH antagonists
- Evaluate the latest safety, efficacy, and clinical differentiators of the GnRH antagonists in improving long-term outcomes for EM management
Sponsored by the Academy for Continued Healthcare Learning (ACHL) and Black Health Matters (BHM).
Supported by an educational grant from Myovant Sciences and Pfizer.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Linda Bradley, MD
Professor Obstetrics, Gynecology & Reproductive Biology
Department of Obstetrics & Gynecology
Cleveland Clinic
Cleveland, OH
Professor Obstetrics, Gynecology & Reproductive Biology
Department of Obstetrics & Gynecology
Cleveland Clinic
Cleveland, OH
Tiara Jones
Patient Testimonial
Arminta McKinney
Patient Testimonial
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
All faculty for this activity, as listed below, have no financial relationships to disclose:
Linda Bradley, MD (Faculty)
Tiara Jones (Patient)
Arminta McKinney (Patient)
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Off-label use of oral contraceptives, GnRH agonists, norethindrone, and medroxyprogesterone acetate for treatment of EM.
ACHL and BHM staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of any ineligible companies. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 60 minutes to complete. To receive credit, learners are required to complete the pretest, view the online activity, and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Ty Jackson at tjackson@achlcme.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.
